3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
A technology of methoxypyrrolidine and methylpyrrolidine, which is applied in the field of therapeutic application and treatment of central nervous system disorders, and can solve the problems of undisclosed medical uses of compounds
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0156] (+)-3-(3-Chloro-2-fluorophenyl)-3-methoxypyrrolidine
[0157] 1-Chloroethylchloromethyl ester (1.42ml, 13.08mmol) was added to (+)-1-benzyl-3-(3-chloro-2-fluorophenyl)-3-methoxypyrrolidine (1.04g, 3.25mmol) in a solution in 1,2-dichloroethane (10ml) and the mixture was heated to reflux for 2 hours after which time the solvent was evaporated. The mixture was dissolved in methanol (20ml), heated to reflux for 1 hour, the solvent was evaporated, and the solvent was evaporated by HPLC on waters OBD C18, 5 μm (MeOH / 33mM NH 3 , 20:80 to 50:50) to afford the title compound 0.47 g (63%). [a] D = +6.5° (methanol). Amine conversion to oxalate, recrystallization from methanol / diethyl ether: M.p. 183-185°C. MS m / z (relative intensity, 70 eV) 229 (M+, 1), 199 (86), 187 (bp), 157 (49), 133 (42).
Embodiment 2
[0159] (+)-3-(3-Chloro-2-fluorophenyl)-1-ethyl-3-methoxypyrrolidine
[0160] Iodoethane (0.13ml, 1.63mmol) was added to (+)-3-(3-chloro-2-fluorophenyl)-3-methoxypyrrolidine (0.25g, 1.08mmol) and triethylamine (0.305ml, 2.17mmol) in tetrahydrofuran (20ml) and the solution was stirred at ambient temperature for 26 hours. Water (20ml) was added, the aqueous phase was extracted with EtOAc (2x50ml), and the combined organic phases were dried (Na 2 SO 4 ), evaporate the solvent. By HPLC in waters OBD C18, 5μm (MeOH / 33mM NH 3 , 20:80 to 65:35) to afford the title compound 0.106 g (38%). [a] D =+16.5° (methanol). Conversion of amine to fumarate, recrystallization from 2-propanol / diisopropanol ether: M.P. 131-133°C. MS m / z (relative intensity, 70 eV) 257 (M+, 9), 242 (bp), 227 (44), 157 (44), 71 (89).
Embodiment 3
[0162] (-)-3-(3-Chloro-2-fluorophenyl)-3-methoxypyrrolidine
[0163] Prepared according to Example 1. (-)-1-benzyl-3-(3-chloro-2-fluorophenyl)-3-methoxypyrrolidine (0.82g, 2.56mmol), 1,2-dichloroethane (10ml ), 1-chloroethyl chloroformate (1.12ml, 10.25mmol) was refluxed for 2 hours, and methanol (20ml) was added to reflux for 1 hour. Purification by HPLC on waters OBD C18, 5 [mu]m (MeOH / 33 mM NH3, 20:80 to 50:50) afforded the title compound (0.38 g, 65%). [a] D = -7.1° (methanol). Amine conversion to oxalate, recrystallization from methanol / diethyl ether: M.p. 183-185°C. MS m / z (relative intensity, 70 eV) 229 (M+, 1), 199 (87), 187 (bp), 157 (55), 133 (51).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com